Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01+0.03 (+3.30%)
Close on Nov 17, 2026Market cap $19.46MP/E –Yield –
Earnings
Cocrystal Pharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2025
–
EPS, Q3 FY2025
-$0.19
-$0.49 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Cocrystal Pharma's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2025ended Dec 31, 2025 | Mar 31, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 14, 2025before the open | – | – | -$0.19 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | – | – | -$0.20 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025before the open | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024during market hours | – | – | -$0.49 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024before the open | – | – | -$0.54 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 13, 2024before the open | – | – | -$0.39 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023before the open | – | – | -$0.41 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 16, 2023during market hours | – | – | -$0.41 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023before the open | – | – | -$0.64 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022before the open | – | – | -$0.25 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022before the open | – | – | -$0.04 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 23, 2022during market hours | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | – | – | -$0.04 | Release |
| Q4 FY2019ended Dec 31, 2019 | Mar 30, 2020before the open | – | – | – | Filing |
| Q2 FY2012ended Jun 30, 2012 | Aug 13, 2012during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Cocrystal Pharma has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Cocrystal Pharma puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Cocrystal Pharma filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Results
- Update
- Update
- Update
- Update
- Results
- Update
- Update
See a number that looks wrong?